Alveolar Soft Part Sarcoma

Search Trials
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma – MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Status:
Recruiting
Last Changed:
Feb 14, 2022
First Changed:
May 30, 2019
Disease(s):
Soft Tissue Sarcoma
Intervention(s):
Patient with Soft Tissue Sarcoma
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Status:
Recruiting
Last Changed:
Nov 26, 2021
First Changed:
Jan 11, 2017
Disease(s):
Alveolar Soft Part Sarcoma
Intervention(s):
AL3818DacarbazineAL3818 or placebo
Testing Atezolizumab and Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma
Status:
Recruiting
Last Changed:
Nov 3, 2021
First Changed:
May 5, 2017
Disease(s):
Metastatic Alveolar Soft Part Sarcoma
Intervention(s):
AtezolizumabBevacizumab
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
Status:
Active, not recruiting
Last Changed:
Feb 1, 2021
First Changed:
Jun 18, 2019
Disease(s):
Sarcoma
Intervention(s):
Hypofractionated radiotherapyHyperthermia
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Status:
Active, not recruiting
Last Changed:
Apr 29, 2022
First Changed:
Jul 3, 2014
Disease(s):
Alveolar Soft Part Sarcoma
Intervention(s):
DoxorubicinDoxorubicin HydrochlorideIfosfamidePazopanibPazopanib HydrochlorideRadiation TherapyTherapeutic Conventional Surgery

Connect. Empower. Inspire.